Mid-sized pharmaceutical companies recorded overall 6% increase of prescription sales in the first half of this year

According to the analysis of prescribing performance of mid-sized pharmaceutical companies (sales of 20~75 billion won range, Ubist based) in the first half of this year, they recorded overall 6% increase in prescription sales.

Among domestic pharmaceutical companies, Hutecs Pharmaceutical (25.8 billion, 27.4% growth) and LG Life Sciences (22.8 billion, 26.6% growth) grew significantly more th...